ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT04159896 · TERMINATED

Trial details

NCT number: NCT04159896
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma Prostate Carcinoma Metastatic in the Bone Stage IVB Prostate Cancer AJCC v8

Start date: 2019-11-13
Primary completion: 2022-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.